A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 486,700 shares of AUPH stock, worth $4.31 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
486,700
Previous 201,500 141.54%
Holding current value
$4.31 Million
Previous $1.15 Million 210.17%
% of portfolio
0.01%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.32 - $7.33 $1.52 Million - $2.09 Million
285,200 Added 141.54%
486,700 $3.57 Million
Q2 2024

Aug 09, 2024

SELL
$4.81 - $5.78 $207,310 - $249,118
-43,100 Reduced 17.62%
201,500 $1.15 Million
Q1 2024

May 13, 2024

BUY
$4.93 - $9.31 $540,328 - $1.02 Million
109,600 Added 81.19%
244,600 $1.23 Million
Q4 2023

Feb 13, 2024

SELL
$7.13 - $9.49 $3.76 Million - $5.01 Million
-528,000 Reduced 79.64%
135,000 $1.21 Million
Q3 2023

Nov 14, 2023

SELL
$7.77 - $12.27 $6.74 Million - $10.6 Million
-867,400 Reduced 56.68%
663,000 $5.15 Million
Q2 2023

Aug 11, 2023

SELL
$8.96 - $11.69 $482,048 - $628,922
-53,800 Reduced 3.4%
1,530,400 $14.8 Million
Q1 2023

May 12, 2023

SELL
$5.94 - $11.27 $409,860 - $777,630
-69,000 Reduced 4.17%
1,584,200 $17.4 Million
Q4 2022

Feb 13, 2023

BUY
$4.11 - $8.14 $3.78 Million - $7.48 Million
919,400 Added 125.29%
1,653,200 $7.14 Million
Q3 2022

Nov 14, 2022

BUY
$6.66 - $12.39 $900,432 - $1.68 Million
135,200 Added 22.59%
733,800 $5.52 Million
Q2 2022

Aug 12, 2022

SELL
$8.95 - $12.8 $9.81 Million - $14 Million
-1,095,600 Reduced 64.67%
598,600 $6.02 Million
Q1 2022

May 13, 2022

BUY
$10.05 - $22.48 $12.3 Million - $27.6 Million
1,227,129 Added 262.73%
1,694,200 $21 Million
Q4 2021

Feb 11, 2022

BUY
$17.78 - $33.08 $8.3 Million - $15.5 Million
467,071 New
467,071 $10.7 Million
Q4 2020

Feb 10, 2021

SELL
$12.94 - $16.05 $3.1 Million - $3.84 Million
-239,400 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$13.19 - $16.66 $12.1 Million - $15.3 Million
-918,100 Reduced 79.32%
239,400 $3.53 Million
Q2 2020

Aug 13, 2020

SELL
$14.12 - $18.33 $3.97 Million - $5.16 Million
-281,300 Reduced 19.55%
1,157,500 $18.8 Million
Q1 2020

May 14, 2020

BUY
$11.34 - $21.46 $9.76 Million - $18.5 Million
860,266 Added 148.7%
1,438,800 $20.9 Million
Q4 2019

Feb 13, 2020

BUY
$3.88 - $21.42 $2.2 Million - $12.2 Million
567,789 Added 5284.22%
578,534 $11.7 Million
Q3 2019

Nov 13, 2019

SELL
$5.34 - $6.59 $309,068 - $381,416
-57,878 Reduced 84.34%
10,745 $57,000
Q2 2019

Aug 12, 2019

SELL
$6.05 - $6.75 $672,015 - $749,769
-111,077 Reduced 61.81%
68,623 $452,000
Q1 2019

May 14, 2019

BUY
$6.06 - $7.64 $1.09 Million - $1.37 Million
179,700 New
179,700 $1.17 Million

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.26B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.